Ikarian Capital »

Corbus Pharmaceuticals Hldgs shares owned by Ikarian Capital

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 196k 6.04
2023-09-30 $1.3M 196k 6.74
2023-06-30 $1.5M 192k 7.84
2023-03-31 $1.4M 192k 7.27

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Corbus Pharmaceuticals Hldgs

Assenagon Asset Management
Ikarian Capital
Vanguard Group
HealthInvest Partners AB
Mirae Asset Global Investments
Royal Bank of Canada
Dimensional Fund Advisors
Cambridge Investment Research Advisors
Cutler
Simplex Trading
JTC Employer Solutions Trustee
Citigroup
Jpmorgan Chase & Co
UBS Group
Advisor Group Holdings

View all funds holding Corbus Pharmaceuticals Hldgs